ATTEC
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- Undisclosed
Investors
- 5
About ATTEC
, dba ATTEC is a protein degradation drug development company, committed to providing novel therapeutic solutions for untargeted disease-causing proteins or non-druggable targets. The company's founder, Professor Ding, is a professor in the School of Life Sciences at Fudan University and has published more than 40 SCI papers in prestigious international journals such as Nature and Cell Research. The company focuses on autophagy-lysosome-targeted degradation of small molecule colloids and uses ATTEC technology to study protein degraders, established the ATTEC small molecule glue screening technology platform and licensed the technique of oblique incident light reflection difference method developed by Yiyan Fei, Associate Researcher of Fudan University. The company generates revenue from providing protein degradation drug and novel therapeutic solutions.
Who invested in ATTEC
5 investors across 3 rounds
See all investors in ATTEC
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ATTEC
Who invested in ATTEC?
ATTEC has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ATTEC raised?
ATTEC has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ATTEC last raise money?
ATTEC's most recent round on record is a Series A, in Feb 2026.
What does ATTEC do?
, dba ATTEC is a protein degradation drug development company, committed to providing novel therapeutic solutions for untargeted disease-causing proteins or non-druggable targets.
Where is ATTEC headquartered?
ATTEC is headquartered in Hangzhou, China.
Which VCs invest in companies like ATTEC?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ATTEC's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ATTEC? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.